Please enable JavaScript to continue using this application.

Compare $GLSI vs $MGNX | Chartloom

Compare

$GLSI vs $MGNX

Greenwich Lifesciences Inc · MacroGenics Inc

GLSI

Greenwich Lifesciences Inc

MGNX

MacroGenics Inc

Compare $GLSI vs $MGNX

Comparing Greenwich Lifesciences Inc and MacroGenics Inc

GLSIGreenwich Lifesciences Inc

MGNXMacroGenics Inc

GLSIGreenwich Lifesciences Inc

Market cap

$243M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-15.1%

52W performance

44.4%

FCF yield

-5.1%

MGNXMacroGenics Inc

Market cap

$238M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

2.39x

Rev growth (TTM)

1.3%

YTD performance

132.3%

52W performance

110.1%

FCF yield

-27.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

GLSI

MGNX

Detailed metrics comparison

GLSI

Greenwich Lifesciences Inc

MGNX

MacroGenics Inc

Market Cap

GLSI$243M

MGNX$238M

Enterprise Value

GLSI$234M

MGNX$302M

Price

GLSI$16.53

MGNX$3.74

P/E Ratio

GLSIN/A

MGNXN/A

P/S Ratio

GLSI0.00x

MGNX1.42x

EV/Sales

GLSI0.00x

MGNX1.80x

EV/EBITDA

GLSI0.00x

MGNX5.31x

P/B Ratio

GLSI79.96x

MGNX5.32x

P/FCF Ratio

GLSIN/A

MGNXN/A

EV/FCF

GLSI-18.72x

MGNX-4.61x

PEG Ratio

GLSIN/A

MGNXN/A

Forward P/E (NTM)

GLSIN/A

MGNXN/A

Forward P/S (NTM)

GLSIN/A

MGNX2.39x

Revenue (TTM)

GLSI$0

MGNX$168M

Revenue Growth (YoY)

GLSIN/A

MGNX1.3%

Forward Rev Growth

GLSI0.0%

MGNX-12.8%

Gross Margin (TTM)

GLSI0.0%

MGNX61.8%

Operating Margin (TTM)

GLSI0.0%

MGNX0.0%

EBITDA Margin (TTM)

GLSI0.0%

MGNX-20.8%

Net Margin (TTM)

GLSI0.0%

MGNX-8.7%

FCF Margin (TTM)

GLSIN/A

MGNX-39.1%

Net Income (TTM)

GLSI$-22M

MGNX$-15M

FCF (TTM)

GLSI$-12M

MGNX$-66M

EPS (TTM)

GLSI-$1.48

MGNX-$0.23

ROE (TTM)

GLSI-79376.0%

MGNX-3127.0%

ROA (TTM)

GLSI-29531.0%

MGNX-535.0%

ROIC (TTM)

GLSI-79376.0%

MGNX-1017.0%

Cash

GLSI$9M

MGNX$114M

Debt

GLSI$0

MGNX$178M

Net Cash/Debt

GLSI$9M

MGNX$-64M

Current Ratio (TTM)

GLSI1.54x

MGNX2.96x

Quick Ratio (TTM)

GLSI1.54x

MGNX2.92x

Debt/Equity (TTM)

GLSI0.00x

MGNX4.16x

Debt/Assets (TTM)

GLSI0.0%

MGNX0.0%

Interest Coverage (TTM)

GLSIN/A

MGNXN/A

Net Debt/EBITDA (TTM)

GLSI0.00x

MGNX0.00x

Beta

GLSI1.54

MGNX1.25

52W Performance

GLSI44.4%

MGNX110.1%

YTD Performance

GLSI-15.1%

MGNX132.3%

% from 52W High

GLSI-51.5%

MGNX-26.4%

% from 52W Low

GLSI112.5%

MGNX189.9%

Asset Turnover (TTM)

GLSI0.00x

MGNX0.61x

FCF Yield (TTM)

GLSI-5.1%

MGNX-27.6%

Earnings Yield (TTM)

GLSI-8.9%

MGNX-6.1%

Dividend Yield (TTM)

GLSIN/A

MGNXN/A

Rule of 40

GLSI0.0

MGNX-37.8

EV/GP/RG

GLSIN/A

MGNXN/A

Ticker research

View GLSI research View MGNX research

Metric	GLSI Greenwich Lifesciences Inc	MGNX MacroGenics Inc
Market & Valuation
Market Cap	$243M	$238M
Enterprise Value	$234M	$302M
Price	$16.53	$3.74
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	1.42x
EV/Sales	0.00x	1.80x
EV/EBITDA	0.00x	5.31x
P/B Ratio	79.96x	5.32x
P/FCF Ratio	N/A	N/A
EV/FCF	-18.72x	-4.61x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	2.39x
Revenue & Growth
Revenue (TTM)	$0	$168M
Revenue Growth (YoY)	N/A	1.3%
Forward Rev Growth	0.0%	-12.8%
Profitability
Gross Margin (TTM)	0.0%	61.8%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-20.8%
Net Margin (TTM)	0.0%	-8.7%
FCF Margin (TTM)	N/A	-39.1%
Net Income (TTM)	$-22M	$-15M
FCF (TTM)	$-12M	$-66M
EPS (TTM)	-$1.48	-$0.23
ROE (TTM)	-79376.0%	-3127.0%
ROA (TTM)	-29531.0%	-535.0%
ROIC (TTM)	-79376.0%	-1017.0%
Financial Health
Cash	$9M	$114M
Debt	$0	$178M
Net Cash/Debt	$9M	$-64M
Current Ratio (TTM)	1.54x	2.96x
Quick Ratio (TTM)	1.54x	2.92x
Debt/Equity (TTM)	0.00x	4.16x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.54	1.25
52W Performance	44.4%	110.1%
YTD Performance	-15.1%	132.3%
% from 52W High	-51.5%	-26.4%
% from 52W Low	112.5%	189.9%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.61x
FCF Yield (TTM)	-5.1%	-27.6%
Earnings Yield (TTM)	-8.9%	-6.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-37.8
EV/GP/RG	N/A	N/A
Ticker research	View GLSI research	View MGNX research

Valuation

P/S Ratio

GLSI

0.00x

MGNX

1.42x

EV/FCF

GLSI

-18.72x

MGNX

-4.61x

Growth & revenue

Revenue Growth TTM

MGNX

1.3%

Forward Revenue Growth

GLSI

0.0%

MGNX

-12.8%

Profitability & performance

Gross Margin

MGNX

61.8%

GLSI

0.0%

ROE

MGNX

-3127.0%

GLSI

-79376.0%

FCF Yield %

GLSI

-5.1%

MGNX

-27.6%

52-Week Performance

MGNX

110.1%

GLSI

44.4%

Detailed metrics comparison

GLSI

Greenwich Lifesciences Inc

MGNX

MacroGenics Inc

Market Cap

GLSI$243M

MGNX$238M

Enterprise Value

GLSI$234M

MGNX$302M

Price

GLSI$16.53

MGNX$3.74

P/E Ratio

GLSIN/A

MGNXN/A

P/S Ratio

GLSI0.00x

MGNX1.42x

EV/Sales

GLSI0.00x

MGNX1.80x

EV/EBITDA

GLSI0.00x

MGNX5.31x

P/B Ratio

GLSI79.96x

MGNX5.32x

P/FCF Ratio

GLSIN/A

MGNXN/A

EV/FCF

GLSI-18.72x

MGNX-4.61x

PEG Ratio

GLSIN/A

MGNXN/A

Forward P/E (NTM)

GLSIN/A

MGNXN/A

Forward P/S (NTM)

GLSIN/A

MGNX2.39x

Revenue (TTM)

GLSI$0

MGNX$168M

Revenue Growth (YoY)

GLSIN/A

MGNX1.3%

Forward Rev Growth

GLSI0.0%

MGNX-12.8%

Gross Margin (TTM)

GLSI0.0%

MGNX61.8%

Operating Margin (TTM)

GLSI0.0%

MGNX0.0%

EBITDA Margin (TTM)

GLSI0.0%

MGNX-20.8%

Net Margin (TTM)

GLSI0.0%

MGNX-8.7%

FCF Margin (TTM)

GLSIN/A

MGNX-39.1%

Net Income (TTM)

GLSI$-22M

MGNX$-15M

FCF (TTM)

GLSI$-12M

MGNX$-66M

EPS (TTM)

GLSI-$1.48

MGNX-$0.23

ROE (TTM)

GLSI-79376.0%

MGNX-3127.0%

ROA (TTM)

GLSI-29531.0%

MGNX-535.0%

ROIC (TTM)

GLSI-79376.0%

MGNX-1017.0%

Cash

GLSI$9M

MGNX$114M

Debt

GLSI$0

MGNX$178M

Net Cash/Debt

GLSI$9M

MGNX$-64M

Current Ratio (TTM)

GLSI1.54x

MGNX2.96x

Quick Ratio (TTM)

GLSI1.54x

MGNX2.92x

Debt/Equity (TTM)

GLSI0.00x

MGNX4.16x

Debt/Assets (TTM)

GLSI0.0%

MGNX0.0%

Interest Coverage (TTM)

GLSIN/A

MGNXN/A

Net Debt/EBITDA (TTM)

GLSI0.00x

MGNX0.00x

Beta

GLSI1.54

MGNX1.25

52W Performance

GLSI44.4%

MGNX110.1%

YTD Performance

GLSI-15.1%

MGNX132.3%

% from 52W High

GLSI-51.5%

MGNX-26.4%

% from 52W Low

GLSI112.5%

MGNX189.9%

Asset Turnover (TTM)

GLSI0.00x

MGNX0.61x

FCF Yield (TTM)

GLSI-5.1%

MGNX-27.6%

Earnings Yield (TTM)

GLSI-8.9%

MGNX-6.1%

Dividend Yield (TTM)

GLSIN/A

MGNXN/A

Rule of 40

GLSI0.0

MGNX-37.8

EV/GP/RG

GLSIN/A

MGNXN/A

Ticker research

View GLSI research View MGNX research

Metric	GLSI Greenwich Lifesciences Inc	MGNX MacroGenics Inc
Market & Valuation
Market Cap	$243M	$238M
Enterprise Value	$234M	$302M
Price	$16.53	$3.74
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	1.42x
EV/Sales	0.00x	1.80x
EV/EBITDA	0.00x	5.31x
P/B Ratio	79.96x	5.32x
P/FCF Ratio	N/A	N/A
EV/FCF	-18.72x	-4.61x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	2.39x
Revenue & Growth
Revenue (TTM)	$0	$168M
Revenue Growth (YoY)	N/A	1.3%
Forward Rev Growth	0.0%	-12.8%
Profitability
Gross Margin (TTM)	0.0%	61.8%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-20.8%
Net Margin (TTM)	0.0%	-8.7%
FCF Margin (TTM)	N/A	-39.1%
Net Income (TTM)	$-22M	$-15M
FCF (TTM)	$-12M	$-66M
EPS (TTM)	-$1.48	-$0.23
ROE (TTM)	-79376.0%	-3127.0%
ROA (TTM)	-29531.0%	-535.0%
ROIC (TTM)	-79376.0%	-1017.0%
Financial Health
Cash	$9M	$114M
Debt	$0	$178M
Net Cash/Debt	$9M	$-64M
Current Ratio (TTM)	1.54x	2.96x
Quick Ratio (TTM)	1.54x	2.92x
Debt/Equity (TTM)	0.00x	4.16x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.54	1.25
52W Performance	44.4%	110.1%
YTD Performance	-15.1%	132.3%
% from 52W High	-51.5%	-26.4%
% from 52W Low	112.5%	189.9%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.61x
FCF Yield (TTM)	-5.1%	-27.6%
Earnings Yield (TTM)	-8.9%	-6.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-37.8
EV/GP/RG	N/A	N/A
Ticker research	View GLSI research	View MGNX research